0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Expression Competent Cells Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-24W5901
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Expression Competent Cells Market Insights and Forecast to 2028
BUY CHAPTERS

Global Expression Competent Cells Market Research Report 2025

Code: QYRE-Auto-24W5901
Report
September 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Expression Competent Cells Market Size

The global market for Expression Competent Cells was valued at US$ 457 million in the year 2024 and is projected to reach a revised size of US$ 889 million by 2031, growing at a CAGR of 10.1% during the forecast period.

Expression Competent Cells Market

Expression Competent Cells Market

The Protein Expression Competent Cell Pack lets you efficiently economically optimize expression by simultaneously testing multiple strains with your gene of interest. The pack includes BL21(DE3) competent cells for nontoxic proteins and BL21(DE3) pLysS competent cells for both toxic and nontoxic proteins.
North American market for Expression Competent Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Expression Competent Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Expression Competent Cells in Protein Expression is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Expression Competent Cells include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Expression Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Expression Competent Cells.
The Expression Competent Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Expression Competent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Expression Competent Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Expression Competent Cells Market Report

Report Metric Details
Report Name Expression Competent Cells Market
Accounted market size in year US$ 457 million
Forecasted market size in 2031 US$ 889 million
CAGR 10.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Chemically Competent Cells
  • Electrocompetent Cells
Segment by Application
  • Protein Expression
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Expression Competent Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Expression Competent Cells Market growing?

Ans: The Expression Competent Cells Market witnessing a CAGR of 10.1% during the forecast period 2025-2031.

What is the Expression Competent Cells Market size in 2031?

Ans: The Expression Competent Cells Market size in 2031 will be US$ 889 million.

Who are the main players in the Expression Competent Cells Market report?

Ans: The main players in the Expression Competent Cells Market are Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics

What are the Application segmentation covered in the Expression Competent Cells Market report?

Ans: The Applications covered in the Expression Competent Cells Market report are Protein Expression, Other

What are the Type segmentation covered in the Expression Competent Cells Market report?

Ans: The Types covered in the Expression Competent Cells Market report are Chemically Competent Cells, Electrocompetent Cells

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Expression Competent Cells Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Expression Competent Cells Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Protein Expression
1.3.3 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Expression Competent Cells Market Perspective (2020-2031)
2.2 Global Expression Competent Cells Growth Trends by Region
2.2.1 Global Expression Competent Cells Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Expression Competent Cells Historic Market Size by Region (2020-2025)
2.2.3 Expression Competent Cells Forecasted Market Size by Region (2026-2031)
2.3 Expression Competent Cells Market Dynamics
2.3.1 Expression Competent Cells Industry Trends
2.3.2 Expression Competent Cells Market Drivers
2.3.3 Expression Competent Cells Market Challenges
2.3.4 Expression Competent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Expression Competent Cells Players by Revenue
3.1.1 Global Top Expression Competent Cells Players by Revenue (2020-2025)
3.1.2 Global Expression Competent Cells Revenue Market Share by Players (2020-2025)
3.2 Global Expression Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Expression Competent Cells Revenue
3.4 Global Expression Competent Cells Market Concentration Ratio
3.4.1 Global Expression Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Expression Competent Cells Revenue in 2024
3.5 Global Key Players of Expression Competent Cells Head office and Area Served
3.6 Global Key Players of Expression Competent Cells, Product and Application
3.7 Global Key Players of Expression Competent Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Expression Competent Cells Breakdown Data by Type
4.1 Global Expression Competent Cells Historic Market Size by Type (2020-2025)
4.2 Global Expression Competent Cells Forecasted Market Size by Type (2026-2031)
5 Expression Competent Cells Breakdown Data by Application
5.1 Global Expression Competent Cells Historic Market Size by Application (2020-2025)
5.2 Global Expression Competent Cells Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Expression Competent Cells Market Size (2020-2031)
6.2 North America Expression Competent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Expression Competent Cells Market Size by Country (2020-2025)
6.4 North America Expression Competent Cells Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Expression Competent Cells Market Size (2020-2031)
7.2 Europe Expression Competent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Expression Competent Cells Market Size by Country (2020-2025)
7.4 Europe Expression Competent Cells Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Expression Competent Cells Market Size (2020-2031)
8.2 Asia-Pacific Expression Competent Cells Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Expression Competent Cells Market Size by Region (2020-2025)
8.4 Asia-Pacific Expression Competent Cells Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Expression Competent Cells Market Size (2020-2031)
9.2 Latin America Expression Competent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Expression Competent Cells Market Size by Country (2020-2025)
9.4 Latin America Expression Competent Cells Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Expression Competent Cells Market Size (2020-2031)
10.2 Middle East & Africa Expression Competent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Expression Competent Cells Market Size by Country (2020-2025)
10.4 Middle East & Africa Expression Competent Cells Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Expression Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Expression Competent Cells Business (2020-2025)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Expression Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Expression Competent Cells Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Expression Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Expression Competent Cells Business (2020-2025)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Expression Competent Cells Introduction
11.4.4 Takara Bio Revenue in Expression Competent Cells Business (2020-2025)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Expression Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Expression Competent Cells Business (2020-2025)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Expression Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Expression Competent Cells Business (2020-2025)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Expression Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Expression Competent Cells Business (2020-2025)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Expression Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Expression Competent Cells Business (2020-2025)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Expression Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Expression Competent Cells Business (2020-2025)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Expression Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Expression Competent Cells Business (2020-2025)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Expression Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Expression Competent Cells Business (2020-2025)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Expression Competent Cells Introduction
11.12.4 Lucigen Revenue in Expression Competent Cells Business (2020-2025)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Expression Competent Cells Introduction
11.13.4 Zymo Research Revenue in Expression Competent Cells Business (2020-2025)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Expression Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Expression Competent Cells Business (2020-2025)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Expression Competent Cells Introduction
11.15.4 Bioline Revenue in Expression Competent Cells Business (2020-2025)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Expression Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Expression Competent Cells Business (2020-2025)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Expression Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Expression Competent Cells Business (2020-2025)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Expression Competent Cells Introduction
11.18.4 Cell Applications Revenue in Expression Competent Cells Business (2020-2025)
11.18.5 Cell Applications Recent Development
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Details
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Expression Competent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Expression Competent Cells Business (2020-2025)
11.19.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Expression Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Expression Competent Cells Business (2020-2025)
11.20.5 Scarab Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Expression Competent Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Chemically Competent Cells
 Table 3. Key Players of Electrocompetent Cells
 Table 4. Global Expression Competent Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Expression Competent Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Expression Competent Cells Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Expression Competent Cells Market Share by Region (2020-2025)
 Table 8. Global Expression Competent Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Expression Competent Cells Market Share by Region (2026-2031)
 Table 10. Expression Competent Cells Market Trends
 Table 11. Expression Competent Cells Market Drivers
 Table 12. Expression Competent Cells Market Challenges
 Table 13. Expression Competent Cells Market Restraints
 Table 14. Global Expression Competent Cells Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Expression Competent Cells Market Share by Players (2020-2025)
 Table 16. Global Top Expression Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Expression Competent Cells as of 2024)
 Table 17. Ranking of Global Top Expression Competent Cells Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Expression Competent Cells Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Expression Competent Cells, Headquarters and Area Served
 Table 20. Global Key Players of Expression Competent Cells, Product and Application
 Table 21. Global Key Players of Expression Competent Cells, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Expression Competent Cells Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Expression Competent Cells Revenue Market Share by Type (2020-2025)
 Table 25. Global Expression Competent Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Expression Competent Cells Revenue Market Share by Type (2026-2031)
 Table 27. Global Expression Competent Cells Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Expression Competent Cells Revenue Market Share by Application (2020-2025)
 Table 29. Global Expression Competent Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Expression Competent Cells Revenue Market Share by Application (2026-2031)
 Table 31. North America Expression Competent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Expression Competent Cells Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Expression Competent Cells Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Expression Competent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Expression Competent Cells Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Expression Competent Cells Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Expression Competent Cells Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Expression Competent Cells Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Expression Competent Cells Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Expression Competent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Expression Competent Cells Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Expression Competent Cells Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Expression Competent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Expression Competent Cells Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Expression Competent Cells Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Merck KGaA Company Details
 Table 47. Merck KGaA Business Overview
 Table 48. Merck KGaA Expression Competent Cells Product
 Table 49. Merck KGaA Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 50. Merck KGaA Recent Development
 Table 51. Thermo Fisher Scientific Company Details
 Table 52. Thermo Fisher Scientific Business Overview
 Table 53. Thermo Fisher Scientific Expression Competent Cells Product
 Table 54. Thermo Fisher Scientific Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 55. Thermo Fisher Scientific Recent Development
 Table 56. Agilent Technologies Company Details
 Table 57. Agilent Technologies Business Overview
 Table 58. Agilent Technologies Expression Competent Cells Product
 Table 59. Agilent Technologies Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 60. Agilent Technologies Recent Development
 Table 61. Takara Bio Company Details
 Table 62. Takara Bio Business Overview
 Table 63. Takara Bio Expression Competent Cells Product
 Table 64. Takara Bio Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 65. Takara Bio Recent Development
 Table 66. Promega Corporation Company Details
 Table 67. Promega Corporation Business Overview
 Table 68. Promega Corporation Expression Competent Cells Product
 Table 69. Promega Corporation Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 70. Promega Corporation Recent Development
 Table 71. Beijing TransGen Biotech Company Details
 Table 72. Beijing TransGen Biotech Business Overview
 Table 73. Beijing TransGen Biotech Expression Competent Cells Product
 Table 74. Beijing TransGen Biotech Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 75. Beijing TransGen Biotech Recent Development
 Table 76. GeneScript Corporation Company Details
 Table 77. GeneScript Corporation Business Overview
 Table 78. GeneScript Corporation Expression Competent Cells Product
 Table 79. GeneScript Corporation Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 80. GeneScript Corporation Recent Development
 Table 81. Yeastern Biotech Company Details
 Table 82. Yeastern Biotech Business Overview
 Table 83. Yeastern Biotech Expression Competent Cells Product
 Table 84. Yeastern Biotech Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 85. Yeastern Biotech Recent Development
 Table 86. New England Biolabs Company Details
 Table 87. New England Biolabs Business Overview
 Table 88. New England Biolabs Expression Competent Cells Product
 Table 89. New England Biolabs Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 90. New England Biolabs Recent Development
 Table 91. QIAGEN N.V. Company Details
 Table 92. QIAGEN N.V. Business Overview
 Table 93. QIAGEN N.V. Expression Competent Cells Product
 Table 94. QIAGEN N.V. Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 95. QIAGEN N.V. Recent Development
 Table 96. OriGene Technologies Company Details
 Table 97. OriGene Technologies Business Overview
 Table 98. OriGene Technologies Expression Competent Cells Product
 Table 99. OriGene Technologies Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 100. OriGene Technologies Recent Development
 Table 101. Lucigen Company Details
 Table 102. Lucigen Business Overview
 Table 103. Lucigen Expression Competent Cells Product
 Table 104. Lucigen Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 105. Lucigen Recent Development
 Table 106. Zymo Research Company Details
 Table 107. Zymo Research Business Overview
 Table 108. Zymo Research Expression Competent Cells Product
 Table 109. Zymo Research Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 110. Zymo Research Recent Development
 Table 111. Bio-Rad Laboratories Company Details
 Table 112. Bio-Rad Laboratories Business Overview
 Table 113. Bio-Rad Laboratories Expression Competent Cells Product
 Table 114. Bio-Rad Laboratories Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 115. Bio-Rad Laboratories Recent Development
 Table 116. Bioline Company Details
 Table 117. Bioline Business Overview
 Table 118. Bioline Expression Competent Cells Product
 Table 119. Bioline Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 120. Bioline Recent Development
 Table 121. Delphi Genetics Company Details
 Table 122. Delphi Genetics Business Overview
 Table 123. Delphi Genetics Expression Competent Cells Product
 Table 124. Delphi Genetics Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 125. Delphi Genetics Recent Development
 Table 126. IBA GmBH Company Details
 Table 127. IBA GmBH Business Overview
 Table 128. IBA GmBH Expression Competent Cells Product
 Table 129. IBA GmBH Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 130. IBA GmBH Recent Development
 Table 131. Cell Applications Company Details
 Table 132. Cell Applications Business Overview
 Table 133. Cell Applications Expression Competent Cells Product
 Table 134. Cell Applications Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 135. Cell Applications Recent Development
 Table 136. BioDynamics Laboratory Company Details
 Table 137. BioDynamics Laboratory Business Overview
 Table 138. BioDynamics Laboratory Expression Competent Cells Product
 Table 139. BioDynamics Laboratory Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 140. BioDynamics Laboratory Recent Development
 Table 141. Scarab Genomics Company Details
 Table 142. Scarab Genomics Business Overview
 Table 143. Scarab Genomics Expression Competent Cells Product
 Table 144. Scarab Genomics Revenue in Expression Competent Cells Business (2020-2025) & (US$ Million)
 Table 145. Scarab Genomics Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Expression Competent Cells Picture
 Figure 2. Global Expression Competent Cells Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Expression Competent Cells Market Share by Type: 2024 VS 2031
 Figure 4. Chemically Competent Cells Features
 Figure 5. Electrocompetent Cells Features
 Figure 6. Global Expression Competent Cells Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Expression Competent Cells Market Share by Application: 2024 VS 2031
 Figure 8. Protein Expression Case Studies
 Figure 9. Other Case Studies
 Figure 10. Expression Competent Cells Report Years Considered
 Figure 11. Global Expression Competent Cells Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Expression Competent Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Expression Competent Cells Market Share by Region: 2024 VS 2031
 Figure 14. Global Expression Competent Cells Market Share by Players in 2024
 Figure 15. Global Top Expression Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Expression Competent Cells as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Expression Competent Cells Revenue in 2024
 Figure 17. North America Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Expression Competent Cells Market Share by Country (2020-2031)
 Figure 19. United States Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Expression Competent Cells Market Share by Country (2020-2031)
 Figure 23. Germany Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Expression Competent Cells Market Share by Region (2020-2031)
 Figure 31. China Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Expression Competent Cells Market Share by Country (2020-2031)
 Figure 39. Mexico Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Expression Competent Cells Market Share by Country (2020-2031)
 Figure 43. Turkey Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Expression Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Merck KGaA Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 48. Agilent Technologies Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 49. Takara Bio Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 50. Promega Corporation Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 51. Beijing TransGen Biotech Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 52. GeneScript Corporation Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 53. Yeastern Biotech Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 54. New England Biolabs Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 55. QIAGEN N.V. Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 56. OriGene Technologies Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 57. Lucigen Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 58. Zymo Research Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 60. Bioline Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 61. Delphi Genetics Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 62. IBA GmBH Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 63. Cell Applications Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 64. BioDynamics Laboratory Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 65. Scarab Genomics Revenue Growth Rate in Expression Competent Cells Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture